Biomedical Embedded Systems Market Size, Share, Industry, Forecast and Outlook (2024-2031)

Global Biomedical Embedded Systems Market is segmented By Component (Software, Hardware), By Application (Wearable Devices, Implantable Devices, Diagnostic Devices, Therapeutic Devices), By End User (Hospitals, Clinics, Home care settings, Others) and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Share, Size, Outlook, and Opportunity Analysis, 2024-2031

Report Overview

Global Biomedical Embedded Systems Market reached US$ 170.25 million in 2023 and is expected to reach US$ 348.74 million by 2031, growing at a CAGR of 9.7% during the forecast period 2024-2031.

Biomedical embedded systems are electronic systems that integrate hardware and software components to monitor, diagnose, and manage various aspects of human health. These systems, consisting of microcontrollers, sensors, and other components, work together to collect and process physiological data. They are embedded in medical devices like wearables, implantables, and diagnostic tools, enabling real-time information delivery, enhanced accuracy, and improved patient outcomes.

Market Scope

For more details on this report – Request for Sample

Market Dynamics: Drivers & Restraints

Rise in the prevalence of chronic diseases

In recent years, with the rise of chronic diseases, there has been a growing need for telemedicine applications such as diagnosis, prognosis, and patient management. Embedded system technologies have occupied an important area in biomedical technology. Especially, to develop tools for the purposes of increasing the safety of healthcare workers in the event of epidemic infectious diseases in processes such as pandemics.

For instance, according to the CDC, in 2024, the US has 129 million people with at least one major chronic disease, including heart disease, cancer, diabetes, obesity, and hypertension. Five of the top 10 leading causes of death in the US are associated with preventable and treatable chronic diseases.

Over the past two decades, prevalence has steadily increased, and this trend is expected to continue. An increasing proportion of Americans are dealing with multiple chronic conditions, with 42% having two or more and 12% having at least five. Chronic diseases also significantly impact the US healthcare system, accounting for 90% of annual $4.1 trillion expenditure.

Vulnerability of embedded systems to security breaches and cyber threats 

One of the key factors slowing industry growth is the security of embedded devices. Military forces, banks, data centers, and healthcare facilities all rely on embedded devices, including memory, to retain potentially critical information. As a result, cybersecurity risks and breaches must be avoided at all costs. 

Market Segment Analysis

The global biomedical embedded systems market is segmented based on component, application, end-user, and region.

The software  from the component segment accounted for approximately 54.1% of the biomedical embedded systems  market share

Software is a vital component in the biomedical embedded systems market, enhancing the functionality and efficiency of medical devices. It integrates complex algorithms and data processing capabilities, managing and interpreting medical data, controlling hardware components, and ensuring real-time responsiveness. 

Software also aids in the development of advanced diagnostics, monitoring, and therapeutic solutions, while supporting regulatory compliance and security measures. As technology advances, software continues to drive innovation and improve the accuracy and reliability of biomedical embedded systems.

For instance, in November 2023, SolidWorld Group S.p.A. upgraded its Electrospider, the first three-dimensional bioprinter capable of replicating human cell tissue, with the incorporation of advanced proprietary Artificial Intelligence. This technological advancement represents a significant step in the future of biomedical engineering.

Market Geographical Share

North America is estimated to hold about 38.4% of the total market share throughout the forecast period

North America is estimated to hold about 38.4% of the total market share throughout the forecast period due to advancements in healthcare technology and increasing demand for advanced medical devices. The region benefits from a strong healthcare infrastructure, high investment in research and development, and a robust presence of leading medical technology companies. Innovations like wearable health monitors, advanced diagnostic tools, and remote patient management systems are crucial for personalized healthcare and improving patient outcomes. North American regulations promote high-quality, safe, and reliable medical devices.

Market Segmentation

By Component

• Software
• Hardware

By Application

• Wearable Devices
• Implantable Devices
• Diagnostic Devices
• Therapeutic Devices

By End User

• Hospitals
• Clinics
• Home care settings
• Others

By Region

• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Rest of Europe
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Asia-Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Middle East and Africa

Market Competitive Landscape

The major global players in the market include Medtronic plc, Philips Healthcare, Siemens Healthineers, General Electric (GE) Healthcare, Roche Diagnostics, Johnson & Johnson, Abbott Laboratories, Boston Scientific Corporation, Texas Instruments, Analog Devices among others.

Key Developments

• In January 2022, Onera Health announced the introduction of its first Onera Biomedical-Lab-on-Chip. The biomedical sensor system-on-chip acquires and processes multiple biosignals and is designed for a broad range of wearable health applications and devices, offering many solutions and opportunities for innovation in the medical, wellness, and fitness space.

Why Purchase the Report?

• To visualize the global biomedical embedded systems market segmentation based on component, application, end-user, and region as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development. 
• Excel data sheet with numerous data points of the biomedical embedded systems market level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of key products of all the major players.

The global biomedical embedded systems market report would provide approximately 64 tables, 61 figures and 186 pages.

Target Audience 2024

• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies